Competition authority interferes with Takeda's deal with Danish Orifarm
Following 'thorough investigations' the Danish Competition and Consumer Authority has approved that Orifarm can take over a range of drugs and factories from Japanese Takeda. However, in return, the firm has to divest several products and rights.
BY IBEN SCHMIDT, TRANSLATED BY NIELSINE NIELSEN
The Danish Competition and Consumer Authority could not approve the whole of Danish supplier company Orifarm's billion-kroner deal with Japanese medical company from last year.